Amprenavir

Overview

Amprenavir (VX-478) is a HIV protease inhibitor (Ki=0.6 nM) used to treat HIV infection . Amprenavir is also a SARS-CoV 3CL pro inhibitor with an IC 50 of 1.09 μM.

Application

Products | Products > Disease Areas > Viral Infection | Products > Disease Areas > Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > HIV | Products > Signaling Pathways > HIV Protease | Products > Signaling Pathways > SARS-CoV

Product Information

• Catalog No.: HY-17430
• CAS No.: 161814-49-9
• Molecular Formula: C25H35N3O6S
• Molecular Weight: 505.63
• Purity: 99.55%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (4.94 mM); Clear solution
• Availability: In-stock

Source

Original product source